Literature DB >> 11598496

Apoptotic and antiapoptotic mechanisms after traumatic brain injury.

R W Keane1, S Kraydieh, G Lotocki, O F Alonso, P Aldana, W D Dietrich.   

Abstract

Caspase and inhibitor of apoptosis (IAP) expression was examined in rats subjected to moderate traumatic brain injury (TBI) using a parasagittal fluid-percussion brain insult (1.7 to 2.2 atm). Within 1 hour after injury, caspase-8 and -9, two initiators of apoptosis, were predominantly expressed in superficial cortical areas adjacent to the impact site and in the thalamus. Caspase-3, an effector caspase, was evident at 6 hours throughout the traumatized cerebral cortex and hippocampus. Moreover, the authors observed that XIAP, cIAP-1, and cIAP-2, members of the IAP family, were constitutively expressed in the brain. Colocalization of XIAP-immunolabled cells with cell-specific markers indicated that XIAP is expressed within neurons and a subpopulation of oligodendrocytes. Immunoblots of brain extracts revealed that the processed forms of caspase-8, -9, and -3 are present as early as 1 hour after trauma. The appearance of activated caspases corresponded with the detection of cleavage of XIAP into fragments after injury and a concomitant increase in the levels of cIAP-1 and cIAP-2 in the traumatized hemispheres. The current data are consistent with the hypotheses that caspases in both the extrinsic and intrinsic apoptotic pathways are activated after moderate TBI and that IAPs may have a protective role within the brain with alterations in levels and cleavage of IAPs that contribute to cell death in this setting.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598496     DOI: 10.1097/00004647-200110000-00007

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  50 in total

1.  Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer.

Authors:  A Mansour; M Nabil; R Ali-Labib; H Said; F Annos
Journal:  Med Oncol       Date:  2011-12-08       Impact factor: 3.064

2.  Neuronal apoptosis following human brain injury.

Authors:  R Hausmann; T Biermann; I Wiest; J Tübel; P Betz
Journal:  Int J Legal Med       Date:  2003-11-18       Impact factor: 2.686

Review 3.  Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

4.  Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats.

Authors:  Erik A Johnson; Stanislav I Svetlov; Kevin K W Wang; Ronald L Hayes; Jose A Pineda
Journal:  Exp Brain Res       Date:  2005-10-29       Impact factor: 1.972

5.  Postinjury treatment with rolipram increases hemorrhage after traumatic brain injury.

Authors:  C M Atkins; Y Kang; C Furones; J S Truettner; O F Alonso; W D Dietrich
Journal:  J Neurosci Res       Date:  2012-04-26       Impact factor: 4.164

6.  A novel protein complex in membrane rafts linking the NR2B glutamate receptor and autophagy is disrupted following traumatic brain injury.

Authors:  Gregory E Bigford; Ofelia F Alonso; Dalton Dietrich; Robert W Keane
Journal:  J Neurotrauma       Date:  2009-05       Impact factor: 5.269

Review 7.  Genetic manipulation of cell death and neuroplasticity pathways in traumatic brain injury.

Authors:  Kathleen M Schoch; Sindhu K Madathil; Kathryn E Saatman
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

Review 8.  Intraoperative Targeted Temperature Management in Acute Brain and Spinal Cord Injury.

Authors:  Jacqueline Kraft; Anna Karpenko; Fred Rincon
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

9.  The expression changes of Numblike in rat brain cortex after traumatic brain injury.

Authors:  Shengyang Jiang; Xiaohong Wu; Yaohua Yan; Jian Xu; Bai Shao; Xun Zhuang; Yingying Han; Xiaosong Gu
Journal:  J Mol Histol       Date:  2012-04-04       Impact factor: 2.611

Review 10.  Pharmaco-proteomics opportunities for individualizing neurovascular treatment.

Authors:  M M Ning; M Lopez; D Sarracino; J Cao; M Karchin; D McMullin; X Wang; F S Buonanno; E H Lo
Journal:  Neurol Res       Date:  2013-06       Impact factor: 2.448

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.